Access & Support

Scalp Cooling Access & Support in Canada

Paxman have been pioneers in scalp cooling technology for more than 20 years. We are proud to be the leading global experts in scalp cooling, with the Paxman Scalp Cooling System being globally recognised as the leading product for hair-loss prevention during chemotherapy treatment.

Find out where Paxman Scalp Cooling is currently available in Canada, please visit our Global Systems Locations Index.

Download the enrolment form

Pricing

How much does Paxman Scalp Cooling cost?

Cost is based on the amount of treatments the patient receives. Treatments 1 through 5 are $400 each, 6 through 7 are $350 each, and 8 through 10 are $100 each. If the patient requires any additional treatments of the same course of chemotherapy, these will be $100 each.
* Please note these costs exclude GST

Is there financial support available for patients?

We are currently working with several financial institutions to provide scalp cooling support, so please get in touch with our Paxman Canada management team. It is Paxman’s aim that every eligible cancer patient, no matter their financial position, has access to support for scalp cooling.

Implementing Scalp Cooling

We want a Paxman system at our site. How do we go about this?

Paxman will work with you to make this process as simple and effective as possible. We have several options that hospitals can consider, including our full-service program where our certified technicians provide all the services, or train hospital staff to provide the treatment. Please contact us at canada@paxmanscalpcooling.com and we will work with you to provide the best option for your hospital.

How will Paxman support my patients?

At Paxman we pride ourselves on providing exceptional patient support - Coldcap.com is there to help patients make an informed choice, guide them through their scalp cooling treatment and provide detailed support before, during and after their chemotherapy treatment. Knowing if cold capping is right for them is a decision only the patient can make. Coldcap.com will lay out everything patients need to know about Paxman scalp cooling to enable them to make an informed decision, and support them through the process. Resources include:
  • Tutorial videos on cap fitting and hair preparation before treatment
  • Our Decision Making Guide, indicating the likelihood of hair retention depending on their chemotherapy type and regimen
  • Haircare advice during cold capping to improve efficacy
  • Our patient pioneer stories

Is there any information on successfully integrating scalp cooling into practice?

Paxman will be there to provide all of the support and training required to efficiently implement scalp cooling, and help to maintain a high standard of care for patients undergoing chemotherapy.

We have also pulled together a list of key clinical considerations when implementing scalp cooling at a cancer centre, based on workflows and clinical papers conducted on efficient scalp cooling practice.

Scalp Cooling Practice

Site Support

How can I manage my patient’s expectations around potential hair retention on their specific chemotherapy regimen?

  • The Scalp Cooling Efficacy Calculator will provide specific information about a patient’s potential hair retention based on data from the Dutch Scalp Cooling Registry
  • The Dutch Registry is a source of data from over 7000 patients, the largest of its kind globally. The Efficacy Calculator uses this data to provide an accurate indication of the likelihood of hair retention for your patient.
  • It is important that this data is interpreted as an indication of what may be possible. The percentages calculated are an average, and your patient may see more or less hair retention. There are no guarantees, but an indication of potential outcome will help to manage your patient’s expectations.
  • The calculator will also provide pre and post cooling times for each regimen.

Our Paxman Management and technical team is also available to help manage patient expectations

Efficacy Calculator

Are there resources available for my site on scalp cooling?

There are a wide range of printed resources available to order from Paxman – please view our Communications Literature Catalogue for more information and how to order.

Literature Catalogue

How do I communicate to my patients about scalp cooling?

After an initial discussion with your patient to introduce scalp cooling, please refer them to our website coldcap.com. This online resource has been designed to help patients reach an informed choice about whether scalp cooling is right for them, then guide them through their treatment. There is also a range of patient literature available to order from our Communications Catalogue, including a patient handout, an introduction to scalp cooling leaflet, and information on foundations and financial support.

I am keen for my patient to educate themselves so they can make an informed choice on scalp cooling. Is there a resource I can send them to?

Our website Coldcap.com is there to help patients make an informed choice, and guide them through their scalp cooling treatment. Knowing if cold capping is right for them is a decision only the patient can make. Coldcap.com will lay out everything patients need to know about Paxman scalp cooling to enable them to make an informed decision, and then go on to support them through the scalp cooling process.

Resources include:

Can I download the enrolment form?

MDL No. 86975
© Paxman Coolers 2022
Paxman Locations
Changing the face of cancer around the world
Europe
Austria
Belgium
Bulgaria
Cyprus
Czech Republic
France >
Georgia
Germany
Greece
Hungary
Italy
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Republic of Ireland
Romania
Russian Federation
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
Asia
Armenia
Bangladesh
Hong Kong
India
Indonesia
Japan
Malaysia
Pakistan
Singapore
South Korea
North & South Amercia
Argentina
Brazil
Iraq
Colombia
Dominican Republic
Mexico
Puerto Rico
Uruguay
US Virgin Islands
Venezuela
Middle East
Bahrain
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Qatar
Saudi Arabia
United Arab Emirates
Africa
Morocco
South Africa
Oceania
Australia
New Zealand